Areas of expertise: Site Management, Clinical Operations, Patient Recruitment and Retention Service Area Expansion, Vendor Management, and Client Engagement and Relationships
Melynda Geurts has over 25 years of experience working at the executive leadership level to facilitate strategic growth within the clinical research market as well as to cultivate a working environment that promoted internal growth. She has been integral in guiding teams in process implementation, clinical development, site management, patient education, and clinical trial enrollment strategies. Melynda served on the executive leadership team of Rheumatology Research International (RRI), a rheumatology focused affiliated Site Management Organization. In this role, Melynda provided the required site support to ensure that all contracted sites met their enrollment targets on time. Melynda also led the creation of D. Anderson & Company (DAC), one of the first centralized, global patient recruitment and retention providers where she was a recognized subject matter expert and a contributor to three published books on the topic. Under her leadership, DAC became a forerunner in the patient recruitment and retention market successfully deploying campaigns across all therapeutic areas, 100+ indications, and 100+ countries. Melynda also demonstrated strong clinical operations oversight in supporting several pharmaceutical and medical device companies to achieve NDA approvals for the studies DAC supported. Melynda continued her patient recruitment and retention efforts through the acquisition of DAC by Imperial Clinical Research Services (ICRS) where she became part of the executive leadership team and provided insight on future M&A activities in the recruitment and retention space.
Melynda also developed expertise in full-CRO services where she serves as the Chief Operating Officer for TOTAL Diversity Clinical Trial Management. In this role, Melynda’s leadership contributions have maintained the CRO’s enrollment goal of meeting 100% of total enrollment for all studies managed. Melynda has established the long-term, positive site and vendor relationships, which are integral to the overall success of studies managed. Through Melynda’s client focus and relationship activities, she has secured an 85%+ repeat client rate. Melynda’s vast experience across the entire clinical trial landscape provides Kinexum with direct, hands-on insight into each of these critical areas withing the clinical development process and ultimately to NDA approval. Melynda received her MS with a concentration in Healthcare Administration from Texas Woman’s University at Dallas, and his BBA in Marketing from Texas Woman’s University at Denton.